Now I have all the information needed. Let me compose the final consolidated review.

---

## Summary

This paper is a rebuttal that systematically addresses seven specific claims made by Palazzo et al. (2024) in a TPAMI response about the comment of Bharadwaj et al. (2023) and the underlying EEG dataset of Ahmed et al. (2021). For each claim, the paper quotes the target statement directly, presents counter-evidence from the cited papers or new analysis, and labels the claim (unfounded, inaccurate, misleading, false, invalid, or unsupported). The only new experiment is a frequency-domain supertrial analysis (Section 7) that demonstrates that even when supertrials are constructed to preserve high-frequency content, EEGChannelNet remains at chance, refuting the claim that the supertrial method biased results against it.

## Strengths

- **Direct, quote-level rebuttal with cited evidence.** Each section quotes the exact claim from Palazzo et al. (2024) and counters it with text from the original papers (Ahmed et al. 2021, Bharadwaj et al. 2023, Li et al. 2021, etc.). This makes the rebuttal verifiable and prevents straw-man arguments. For example, the single-subject claim (Section 6) is falsified by quoting Bharadwaj et al.'s own statement that they used six subjects from Li et al. (2021), and the session-length claim (Section 4) is corrected using the original tables from Spampinato et al. (2017).

- **New frequency-domain supertrial experiment (Section 7, Table 1, Figure 1).** The paper constructs supertrials by averaging magnitude and phase independently in the frequency domain — a construction that does not induce phase cancellation — and shows that EEGChannelNet still yields chance accuracy while other models remain above chance. This directly addresses the claim that the supertrial method "unavoidably" attenuates high frequencies and penalizes EEGChannelNet.

- **Clear logical refutation of the confound defense (Section 8).** The paper correctly identifies that the BDB blank-screen analysis in Palazzo et al. (2020b) measures temporal correlation *between* runs, not *within* runs where the actual confound operates, and correctly invokes the logical principle that failing to detect a confound does not prove its absence. The distinction between confounds (which inflate accuracy) and data-quality concerns (which suppress it) is well-made using the APA definition.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

- **Factual inaccuracy in describing the spectral analysis (Section 7, lines 210–211).** The paper states: *"It can be seen that this does not attenuate higher-frequency components. In fact, it amplifies them."* The figure caption states the opposite: *"raw trials having the highest power and the 100 supertrial size having the lowest power."* The figure confirms the caption: all supertrial spectra lie *below* the raw-trial spectrum at every frequency. There is no amplification. The intended point — that frequency-domain averaging does not *selectively* suppress high frequencies relative to low frequencies — is valid and sufficient, but the word "amplifies" is incorrect and contradicts the paper's own figure. This does not undermine the core conclusion but must be corrected.

- **Genre fit.** The paper is a commentary/rebuttal — a response to a response to a comment. It does not present a novel method, dataset, or broad empirical finding. While correcting the scientific record is a legitimate contribution, the paper's format ("Paper under double-blind review") suggests submission to a research conference where this genre is atypical. The contribution should be evaluated in context.

- **Ethics statement makes a sweeping claim ("nearly one hundred papers")** that is rhetorically separate from the core rebuttal. This claim is not evidenced within the paper's main argument (the paper does not analyze each of those papers individually). While this section is flagged as opinion/summary and does not affect the technical rebuttal, it may color the paper's overall tone.

### Trivial

- Table 1 uses p < 0.005 (binomial CMF) across 88 entries without discussing multiple comparisons. The pattern is robust (EEGChannelNet never significant, other classifiers significant across many conditions), so this does not affect conclusions, but a brief note would strengthen rigor.
- Figure 1 labels "1" as a supertrial size, which could be read as "raw trials" by a casual reader (the header says "raw trials (blue)" and "1 (orange)" — these are in fact the same thing, which is confusing).

## Nice-to-Haves

- The "amplifies" misstatement in Section 7 should be replaced with something like "does not selectively attenuate higher-frequency components relative to lower-frequency ones; the spectral shape is preserved." This is the correct and sufficient claim.
- A brief note on why frequency-domain averaging (separating magnitude and phase) avoids the phase-cancellation issue that time-domain averaging encounters would improve methodological clarity.
- The paper could explicitly note that the consistent null result for EEGChannelNet across all 11 supertrial sizes (Table 1) makes the conclusion robust despite the unadjusted significance threshold.

## Removed Points

- The harsh critic's concern about whether a rebuttal/commentary is "appropriate for a conference" is kept as a minor weakness (genre fit) rather than treated as fatal, consistent with the rule that a paper should be evaluated on its own merits.
- The harsh critic's concern about the "nearly one hundred papers" claim in the ethics statement is kept in weakened form as a minor observation about rhetoric, consistent with the rule that the ethics statement is separate from the core rebuttal.
- Strength Finder's strengths about "clarification of temporal confound" and "factual correction of session-length" are merged into the main strengths or subsumed by the direct-evidence strength; they are not listed as separate items.
- The "signal bleeding" and "subject attentiveness" rebuttals (Sections 2–3) rely on logical argument rather than new data, but this is appropriate for a rebuttal paper and not a weakness; the argument is reasonable given the cited design parameters.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. Correct the "amplifies them" statement in Section 7 to accurately describe the spectral comparison (e.g., "preserves the spectral shape" or "does not selectively attenuate higher frequencies").
2. Add a sentence clarifying that 88 tests at p < 0.005 yields <0.5 expected false positives, and the consistent pattern across conditions makes the conclusion robust.
3. Consider re-labeling the "1" supertrial size in Figure 1 more clearly (e.g., "size 1 (i.e., single trials)") to avoid confusion with raw trials.

## Score and Decision

### Calibration Report

**Round 1 (Bracketing):** Three queries on rebuttal/critique-of-published-work papers:
- Low bracket (score < 3.5): found papers scoring 2.00–3.25 (unrelated topics).
- Middle bracket (3.5–7.5): found "Is Memorization Actually Necessary for Generalization?" (avg score 4.40, sim 0.63–0.64) — the closest analog; also "Provable Privacy Attacks" (6.00, different genre).
- High bracket (>7.5): found papers scoring 8.00 (unrelated topics — GNN certification, protein generation, etc.).

**Round 2 (Narrowing):** Three queries targeting the 3.5–7.5 range for rebuttal/critique papers:
- "Is Memorization Actually Necessary for Generalization?" appeared again (scores 3.75 and 4.40 across two versions). Both were rejected. The reviews highlight: the paper's claims were seen as overly strong, its methodology questionable on sub-population analysis, and its contribution described as "minimal" (reviewer at score 6: "good science but really just above what I'd consider sufficient").

**Comparison to anchors:** The paper under review is substantially stronger than the 3.75–4.40 memorization anchors. It is more focused (specific quote-level rebuttals vs. broad methodological critique), its evidence is more direct and verifiable, and its new experiment cleanly addresses the central supertrial claim. The factual error in Section 7 ("amplifies") is the only substantive flaw, and it is easily correctable. However, the paper is a rebuttal/commentary rather than a standard research contribution, which limits its ceiling.

**Final bracket:** 4.5–6.5 → narrowed to 5.5.

### Score and Decision

**Score: 5.5**

**Decision: Weak Accept** — The paper successfully refutes seven specific claims with direct evidence and a clean new experiment. The only substantive error is a misstatement in Section 7 that contradicts the paper's own figure and is easily corrected. For a rebuttal/commentary, the contribution — correcting the scientific record on a contentious issue with downstream implications for many papers — is solid and well-executed. The paper should be accepted contingent on correcting the "amplifies" inaccuracy.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Accept</decision>